| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash provided by financing activities | 6,242 | 4,996 |
| Net (decrease) increase in cash and cash equivalents | -973 | 94 |
| Cash and cash equivalents at beginning of period | 5,028 | - |
| Cash and cash equivalents at end of period | 4,055 | - |
GRI Bio, Inc. (GRI)
GRI Bio, Inc. (GRI)